
    
      A multi-centre real-world non-interventional observational study to retrospectively collect
      the study data on patient demographic/tumor biological characteristics and clinical
      treatments to compare patient survivals in the N2 patients with non-small cell lung cancer in
      the subgroups of lymph skip metastases and non-skip metastases.
    
  